The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Northwestern University
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)